KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $59,000 | -68.6% | 13,137 | -27.9% | 0.01% | -72.2% |
| Q2 2021 | $188,000 | -62.0% | 18,229 | -61.3% | 0.02% | -48.6% |
| Q1 2021 | $495,000 | -36.1% | 47,054 | -6.1% | 0.04% | -58.3% |
| Q4 2020 | $775,000 | +682.8% | 50,086 | +387.8% | 0.08% | +950.0% |
| Q3 2019 | $99,000 | -49.2% | 10,267 | -10.5% | 0.01% | -33.3% |
| Q3 2018 | $195,000 | -41.3% | 11,466 | -53.6% | 0.01% | -33.3% |
| Q1 2018 | $332,000 | +65.2% | 24,710 | +35.1% | 0.02% | +80.0% |
| Q3 2017 | $201,000 | – | 18,293 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |